Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Long-Term Debt Repayments: 2019-2020

Historic Long-Term Debt Repayments for Avidity Biosciences (RNA) over the last 2 years, with Dec 2020 value amounting to $4.7 million.

  • Avidity Biosciences' Long-Term Debt Repayments was N/A to $4.0 million in Q2 2020 from the same period last year, while for Jun 2020 it was $6.1 million, marking a year-over-year change of. This contributed to the annual value of $4.7 million for FY2020, which is 67.25% up from last year.
  • According to the latest figures from FY2020, Avidity Biosciences' Long-Term Debt Repayments is $4.7 million, which was up 67.25% from $2.8 million recorded in FY2019.
  • In the past 5 years, Avidity Biosciences' Long-Term Debt Repayments registered a high of $4.7 million during FY2020, and its lowest value of $2.8 million during FY2019.
  • Moreover, its 2-year median value for Long-Term Debt Repayments was $3.7 million (2019), whereas its average is $3.7 million.
  • Data for Avidity Biosciences' Long-Term Debt Repayments shows a peak YoY spiked of 67.25% (in 2020) over the last 5 years.
  • Avidity Biosciences' Long-Term Debt Repayments (Yearly) stood at $2.8 million in 2019, then surged by 67.25% to $4.7 million in 2020.